Crinetics Pharmaceuticals Operating Expenses 2017-2024 | CRNX
Crinetics Pharmaceuticals operating expenses for the twelve months ending September 30, 2024 were $0.308B, a 45.04% increase year-over-year.
- Crinetics Pharmaceuticals annual operating expenses for 2023 were $0.227B, a 31.28% increase from 2022.
- Crinetics Pharmaceuticals annual operating expenses for 2022 were $0.173B, a 58.69% increase from 2021.
- Crinetics Pharmaceuticals annual operating expenses for 2021 were $0.109B, a 44.99% increase from 2020.